AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 156 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $334,347 | -59.5% | 13,509 | -53.6% | 0.00% | 0.0% |
| Q2 2023 | $825,244 | +32.6% | 29,140 | +7.5% | 0.00% | 0.0% |
| Q1 2023 | $622,532 | -8.6% | 27,102 | +11.8% | 0.00% | 0.0% |
| Q4 2022 | $680,968 | -0.0% | 24,251 | +0.7% | 0.00% | 0.0% |
| Q3 2022 | $681,000 | +26.6% | 24,086 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $538,000 | -42.3% | 24,276 | -24.3% | 0.00% | 0.0% |
| Q1 2022 | $933,000 | -17.2% | 32,068 | -6.5% | 0.00% | 0.0% |
| Q4 2021 | $1,127,000 | – | 34,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |